全文获取类型
收费全文 | 11464篇 |
免费 | 804篇 |
国内免费 | 27篇 |
专业分类
耳鼻咽喉 | 81篇 |
儿科学 | 377篇 |
妇产科学 | 186篇 |
基础医学 | 2159篇 |
口腔科学 | 263篇 |
临床医学 | 949篇 |
内科学 | 2064篇 |
皮肤病学 | 521篇 |
神经病学 | 1289篇 |
特种医学 | 485篇 |
外科学 | 1166篇 |
综合类 | 64篇 |
一般理论 | 1篇 |
预防医学 | 718篇 |
眼科学 | 142篇 |
药学 | 781篇 |
中国医学 | 5篇 |
肿瘤学 | 1044篇 |
出版年
2023年 | 53篇 |
2022年 | 95篇 |
2021年 | 186篇 |
2020年 | 118篇 |
2019年 | 179篇 |
2018年 | 249篇 |
2017年 | 183篇 |
2016年 | 253篇 |
2015年 | 270篇 |
2014年 | 344篇 |
2013年 | 456篇 |
2012年 | 683篇 |
2011年 | 688篇 |
2010年 | 365篇 |
2009年 | 403篇 |
2008年 | 629篇 |
2007年 | 657篇 |
2006年 | 676篇 |
2005年 | 629篇 |
2004年 | 675篇 |
2003年 | 578篇 |
2002年 | 580篇 |
2001年 | 312篇 |
2000年 | 260篇 |
1999年 | 248篇 |
1998年 | 169篇 |
1997年 | 110篇 |
1996年 | 95篇 |
1995年 | 121篇 |
1994年 | 90篇 |
1993年 | 97篇 |
1992年 | 119篇 |
1991年 | 125篇 |
1990年 | 131篇 |
1989年 | 114篇 |
1988年 | 93篇 |
1987年 | 87篇 |
1986年 | 90篇 |
1985年 | 85篇 |
1984年 | 82篇 |
1983年 | 66篇 |
1982年 | 52篇 |
1981年 | 51篇 |
1980年 | 43篇 |
1979年 | 75篇 |
1978年 | 46篇 |
1977年 | 47篇 |
1974年 | 45篇 |
1973年 | 54篇 |
1968年 | 43篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
van der Heijden Amber A. W. A. de Bruijne Martine C. Nijpels Giel Hugtenburg Jacqueline G. 《International journal of clinical pharmacy》2019,41(4):963-971
International Journal of Clinical Pharmacy - Background Drug-related problems (DRP) following hospital discharge may cause morbidity, mortality and hospital re-admissions. It is unclear whether a... 相似文献
5.
André Ricardo Adriano Tiago Silveira Lima Maxime Battistella Martine Bagot 《Anais brasileiros de dermatologia》2015,90(6):892-895
Granulomatous slack skin is an indolent T-cell lymphoma, considered to be a
variant of mycosis fungoides. Clinically it is characterized by areas of
redundant skin, wrinkled, inelastic, with variable erythema and
infiltration besides a poikilodermic surface. A differential diagnosis
unknown to most dermatologists is the giant cell tumor of soft tissue,
which is an extremely rare low-grade sarcoma. The authors report a patient
who had undergone extensive surgery because of a primary diagnosis of giant
cell tumor of soft tissue, but which proved to be granulomatous slack skin
after a second interventional procedure with confirmatory
histopathology. 相似文献
6.
Adeline Tarantini Sylvie Huet Gérard Jarry Rachelle Lanceleur Martine Poul Ana Tavares Nádia Vital Henriqueta Louro Maria João Silva Valérie Fessard 《Environmental and molecular mutagenesis》2015,56(2):218-227
Synthetic amorphous silica (SAS) in its nanosized form is now used in food applications although the potential risks for human health have not been evaluated. In this study, genotoxicity and oxidative DNA damage of two pyrogenic (NM‐202 and 203) and two precipitated (NM‐200 and ‐201) nanosized SAS were investigated in vivo in rats following oral exposure. Male Sprague Dawley rats were exposed to 5, 10, or 20 mg/kg b.w./day for three days by gavage. DNA strand breaks and oxidative DNA damage were investigated in seven tissues (blood, bone marrow from femur, liver, spleen, kidney, duodenum, and colon) with the alkaline and the (Fpg)‐modified comet assays, respectively. Concomitantly, chromosomal damage was investigated in bone marrow and in colon with the micronucleus assay. Additionally, malondialdehyde (MDA), a lipid peroxidation marker, was measured in plasma. When required, a histopathological examination was also conducted. The results showed neither obvious DNA strand breaks nor oxidative damage with the comet assay, irrespective of the dose and the organ investigated. Similarly, no increases in chromosome damage in bone marrow or lipid peroxidation in plasma were detected. However, although the response was not dose‐dependent, a weak increase in the percentage of micronucleated cells was observed in the colon of rats treated with the two pyrogenic SAS at the lowest dose (5 mg/kg b.w./day). Additional data are required to confirm this result, considering in particular, the role of agglomeration/aggregation of SAS NMs in their uptake by intestinal cells. Environ. Mol. Mutagen. 56:218–227, 2015. © 2014 Wiley Periodicals, Inc. 相似文献
7.
8.
9.
10.
Decreases in sex hormone levels with menopause may bring about a number of consequences in women's general health and sexual well-being, especially when levels decline suddenly and prematurely, as in surgical menopause. In addition to the well-established role of estrogens in preserving the biological basis of sexual response, there is emerging evidence that androgens are significant independent determinants affecting sexual desire, activity and satisfaction, as well as mood, energy and other components of women's health. Hypoactive sexual desire disorder (HSDD), a persistent absence of sexual fantasies or thoughts and/or desire for and receptivity to sexual activity that causes personal distress, is experienced by some postmenopausal women. Even though conventional hormone therapy with estrogens or estrogens and progestogens may be effective for vaginal atrophy, increasing vaginal lubrication and reducing dyspareunia, it has not been shown to consistently increase sexual desire or activity and many women with sexual dysfunction remain unresponsive. Several recent, large, phase III studies have shown that the addition of transdermal testosterone to conventional hormone therapy can be helpful in surgically menopausal women presenting with HSDD. After 24 weeks of treatment in these studies, testosterone-treated women experienced significantly greater increases in satisfying sexual activity and sexual desire, and greater decreases in distress, than placebo-treated women. Accurate clinical assessment and individualized management of sexual symptoms are fundamentally important for all menopausal women with HSDD or other sexual problems. 相似文献